Danske Bank’s Cardlytics CDLX Stock Holding History

Danske Bank’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6	Hold	2	–	–	﹤0.01%	1082
2026 Q2	$9	Buy	+2	New	+$15	﹤0.01%	1068

Other funds holding CDLX

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

KPS Global Asset Management (UK) London, United Kingdom $625M AUM 17% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

RBF Capital San Francisco, California $2.3B AUM 22.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Quinn Opportunity Partners Charlottesville, Virginia $1.85B AUM 1.27% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Danske Bank's CDLX Position: Q3 2026 in Review

Danske Bank held its Cardlytics (CDLX) position steady in Q3 2026 at 2 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #1082.

Danske Bank first reported a position in CDLX in Q2 2026 and has held it in 2 quarters since. The position peaked at $9 in Q2 2026. 31 funds tracked by Wall St. Rank hold CDLX as of Q3 2026.

Danske Bank held 2 shares of Cardlytics worth $6 as of Q3 2026.
Danske Bank left its Cardlytics share count unchanged in Q3 2026.
Cardlytics made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #1082 holding.
Danske Bank first reported a position in Cardlytics in Q2 2026 and has held it in 2 quarters since.
Danske Bank's Cardlytics position peaked at $9 in Q2 2026.
31 funds tracked by Wall St. Rank held Cardlytics as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.